In the murine CRC model, CD11b+ Ly6C+ MHC-II+ cells, an intermediate state from monocytes to TAMs, accumulated in the tumor environment, where MEK inhibition suppressed macrophage polarization [77]. The gene discussed is MAP2K7; the disease is neoplasm.